Total Holdings
74
As of Oct 4, 2026
Invesco S&P SmallCap Health Care ETF
PSCHNASDAQInvescoEquity
$51.89Today:- (-)1Y +25.36%
As of Oct 16, 2026 close
- Assets (AUM)
- $182.15M
- Expense ratio
- 0.29%
- Dividend yield
- 0.00%
- Holdings
- 74
- 52-week range
- $39.08$56.45
- Volume (live)
- -
- Avg. volume (3M)
- 18.08K
PSCH ETF Holdings: Invesco S&P SmallCap Health Care ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
35.6%
Share of fund assets
Assets (AUM)
$182.15M
Total fund assets
Expense Ratio
0.29%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 51 of 74 PSCH Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 51 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Glaukos Corporation | Stock | 5.25% |
| 2 |  | Protagonist Therapeutics, Inc. | Stock | 4.92% |
| 3 |  | TG Therapeutics, Inc | Stock | 4.35% |
| 4 |  | Alkermes plc | Stock | 3.80% |
| 5 |  | Ligand Pharmaceuticals Incorporated | Stock | 3.28% |
| 6 |  | PTC Therapeutics, Inc. | Stock | 2.88% |
| 7 |  | Teleflex Incorporated | Stock | 2.86% |
| 8 |  | Liquidia Corporation | Stock | 2.81% |
| 9 |  | Merit Medical Systems, Inc | Stock | 2.78% |
| 10 |  | RadNet Inc | Stock | 2.69% |
| 11 |  | Integer Holdings Corporation | Stock | 2.33% |
| 12 | INDV | Indivior Pharmaceuticals, Inc. | Stock | 2.29% |
| 13 |  | Concentra Group Holdings Parent, Inc. | Stock | 2.29% |
| 14 |  | ICU Medical, Inc | Stock | 2.21% |
| 15 |  | Veracyte, Inc | Stock | 2.08% |
| 16 |  | Amneal Pharmaceuticals, Inc. | Stock | 2.03% |
| 17 |  | Organon & Co. | Stock | 1.96% |
| 18 |  | LifeStance Health Group, Inc. | Stock | 1.73% |
| 19 |  | AtriCure, Inc | Stock | 1.65% |
| 20 |  | Waystar Holding Corp. | Stock | 1.63% |
| 21 |  | Arcutis Biotherapeutics, Inc | Stock | 1.60% |
| 22 |  | Neogen Corporation | Stock | 1.59% |
| 23 |  | National HealthCare Corporation | Stock | 1.57% |
| 24 |  | TransMedics Group, Inc | Stock | 1.55% |
| 25 |  | ACADIA Pharmaceuticals Inc | Stock | 1.53% |
| 26 | NYSE MKT:NHC | National HealthCare Corporation | Stock | 1.50% |
| 27 |  | Acadia Healthcare Company, Inc. | Stock | 1.42% |
| 28 |  | Privia Health Group, Inc. | Stock | 1.41% |
| 29 |  | Supernus Pharmaceuticals, Inc | Stock | 1.34% |
| 30 |  | NeoGenomics, Inc | Stock | 1.34% |
| 31 |  | UFP Technologies Inc | Stock | 1.23% |
| 32 |  | CorVel Corporation | Stock | 1.21% |
| 33 |  | Arcus Biosciences, Inc | Stock | 1.21% |
| 34 |  | Prestige Consumer Healthcare Inc | Stock | 1.15% |
| 35 |  | ADMA Biologics, Inc | Stock | 1.14% |
| 36 |  | Addus HomeCare Corporation | Stock | 1.11% |
| 37 |  | Harmony Biosciences Holdings Inc | Stock | 1.09% |
| 38 |  | Perrigo Company plc | Stock | 1.09% |
| 39 |  | Pediatrix Medical Group, INC | Stock | 1.09% |
| 40 |  | Vericel Corporation | Stock | 1.07% |
| 41 |  | Progyny, Inc | Stock | 1.06% |
| 42 |  | Inspire Medical Systems, Inc | Stock | 1.06% |
| 43 |  | Sarepta Therapeutics, Inc | Stock | 1.04% |
| 44 |  | Fortrea Holdings Inc. | Stock | 1.02% |
| 45 |  | LeMaitre Vascular, Inc | Stock | 0.92% |
| 46 |  | Schrödinger, Inc | Stock | 0.90% |
| 47 |  | BioLife Solutions Inc | Stock | 0.89% |
| 48 |  | Xencor, Inc | Stock | 0.87% |
| 49 |  | Omnicell, Inc | Stock | 0.80% |
| 50 |  | Innoviva, Inc | Stock | 0.80% |
| 51 |  | ANI Pharmaceuticals, Inc | Stock | 0.80% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Invesco S&P SmallCap Health Care ETF Holdings
What are the top holdings in PSCH?
As of Oct 4, 2026, Invesco S&P SmallCap Health Care ETF (PSCH) holds 74 securities. The largest are Glaukos Corporation (5.25%), Protagonist Therapeutics, Inc. (4.92%), TG Therapeutics, Inc (4.35%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is PSCH's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 35.6% of PSCH's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is PSCH's sector allocation?
The Sector Allocation chart shows how PSCH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PSCH invest in?
PSCH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PSCH ETF?
PSCH's diversification can be assessed by reviewing its 74 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.